Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs

Journal of Toxicological Sciences

Volumn 27, Issue 3, 2002, Pages 219-228

  Nagai, Akio ^a   Miyazaki, Miyono ^a   Morita, Teiichi ^a   Furubo, Shinichi ^a   Kizawa, Kazuo ^a   Fukumoto, Hiroyuki ^a   Sanzen, Takahiro ^a   Hayakawa, Hiroyoshi ^a   Kawamura, Yasuhito ^a  

^a TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

Articular toxicity; Garenoxacin; Juvenile dog; Quinolone

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; GARENOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; T 381; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTHROPATHY; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DOG; ELBOW; HISTOPATHOLOGY; KNEE; NONHUMAN; SHOULDER; TOXICITY TESTING;

ANIMALIA; CANIS FAMILIARIS;

EID: 0036693207     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.27.219     Document Type: Article

References (34)

1. Safety overview: Toxicity, adverse effects and drug interactions
2. Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children
3. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: Comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations
4. Nalidixic acid and bacterial chromosome replication
5. Evaluation of norfloxacin in the pediatric field
6. Antibacterial spectrum of a novel desfluoro(6) quinolone, BMS-284756
7. T-3811, a novel des-F(6)-quinolone: Comparative studies of the adverse reactions associated with quinolones
8. DNA gyrase; an enzyme that introduces superhelical turns into DNA
9. Fluoroquinolone antibacterials: SAR, mechanism of action, resistance and clinical aspects
10. Quinolone arthropathy: Acute toxicity to immature cartilage
11. Ciprofloxacin in pediatrics: Worldwide clinical experience based on compassionate use - Safety report
12. Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: Efficacious or contraindicated?
13. Ciprofloxacin safety in a pediatric population
14. Prostatitis, epididymitis
15. Ciprofloxacin use: Acute arthropathy and long-term follow up
16. Fluoroquinolone toxicity profiles: A review focusing on newer agents
17. Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals
18. T-3811, a novel des-F(6)-quinolone: Toxicological evaluation
19. Studies on the interaction of pyridone carboxylic acids with metals
20. Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: Comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging
21. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis
22. Use of the quinolones in pediatrics
23. Quinolones in children: Are concerns over arthropathy justified?
24. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy
25. Toxicity of quinolones
26. Chondrotoxicity of ciprofloxacin in immature Beagle dogs; Immunohistochemistry, electron microscopy and drug plasma concentrations
27. Effects of magnesium deficiency on joint cartilage in immature Beagle dogs: Immunohistochemistry, electron microscopy, and mineral concentrations
28. Safety overview
29. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone
30. Clinical pharmacology of norfloxacin - Little child
31. DNA topoisomerases
32. Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones